PL374489A1 - Nowe podstawione kwasy aryloheksadienowe i ich estry, mające zastosowanie do leczenia i zapobiegania cukrzycy, dyslipidemii i miażdżycy tętnic, zawierające je kompozycje farmaceutyczne oraz sposoby ich otrzymywania - Google Patents

Nowe podstawione kwasy aryloheksadienowe i ich estry, mające zastosowanie do leczenia i zapobiegania cukrzycy, dyslipidemii i miażdżycy tętnic, zawierające je kompozycje farmaceutyczne oraz sposoby ich otrzymywania

Info

Publication number
PL374489A1
PL374489A1 PL03374489A PL37448903A PL374489A1 PL 374489 A1 PL374489 A1 PL 374489A1 PL 03374489 A PL03374489 A PL 03374489A PL 37448903 A PL37448903 A PL 37448903A PL 374489 A1 PL374489 A1 PL 374489A1
Authority
PL
Poland
Prior art keywords
dyslipidaemia
atherosclerosis
diabetes
prevention
processes
Prior art date
Application number
PL03374489A
Other languages
English (en)
Inventor
Michel Brunet
Jean-Jacques Zeiller
Gerard Ferrand
Yves Bonhomme
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL374489A1 publication Critical patent/PL374489A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL03374489A 2002-10-01 2003-08-11 Nowe podstawione kwasy aryloheksadienowe i ich estry, mające zastosowanie do leczenia i zapobiegania cukrzycy, dyslipidemii i miażdżycy tętnic, zawierające je kompozycje farmaceutyczne oraz sposoby ich otrzymywania PL374489A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212135A FR2845087B1 (fr) 2002-10-01 2002-10-01 Nouveaux acides arylhexadienoiques substitues et leurs esters,utilisables dans le traitement et la prevention du diabete, des dyslipidemies,de l'atherosclerose, compositions pharmaceutiques les contenant et procedes de preparation

Publications (1)

Publication Number Publication Date
PL374489A1 true PL374489A1 (pl) 2005-10-31

Family

ID=31985377

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374489A PL374489A1 (pl) 2002-10-01 2003-08-11 Nowe podstawione kwasy aryloheksadienowe i ich estry, mające zastosowanie do leczenia i zapobiegania cukrzycy, dyslipidemii i miażdżycy tętnic, zawierające je kompozycje farmaceutyczne oraz sposoby ich otrzymywania

Country Status (21)

Country Link
US (1) US7737176B2 (pl)
EP (1) EP1546083B1 (pl)
JP (1) JP4486499B2 (pl)
KR (1) KR20050070026A (pl)
CN (1) CN1325462C (pl)
AT (1) ATE477232T1 (pl)
AU (1) AU2003255412B2 (pl)
BR (1) BR0314826A (pl)
CA (1) CA2500649C (pl)
CY (1) CY1110814T1 (pl)
DE (1) DE60333765D1 (pl)
DK (1) DK1546083T3 (pl)
ES (1) ES2350101T3 (pl)
FR (1) FR2845087B1 (pl)
MX (1) MXPA05003388A (pl)
PL (1) PL374489A1 (pl)
PT (1) PT1546083E (pl)
RU (1) RU2005113717A (pl)
SI (1) SI1546083T1 (pl)
WO (1) WO2004031116A1 (pl)
ZA (1) ZA200503416B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013177360A (ja) 2011-08-02 2013-09-09 Sumitomo Chemical Co Ltd α−ケトアルデヒド化合物の製造方法
EP2758041B1 (de) 2011-09-20 2021-01-13 Basf Se Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615157A1 (de) * 1986-05-05 1987-11-12 Schwabe Willmar Gmbh & Co 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe
RU2051673C1 (ru) * 1992-02-07 1996-01-10 Общество с ограниченной ответственностью "ЛОШТАК" Антиатеросклеротическое и антиатерогенное средство
FR2849849B1 (fr) * 2003-01-13 2006-08-04 Merck Sante Sas Nouveaux acides carboxyliques et derives pour le traitement et la prevention du diabete et des dyslipemies
FR2869610B1 (fr) * 2004-05-03 2006-07-28 Merck Sante Soc Par Actions Si Derives de l'acide pentenoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et leurs applications therapeutiques

Also Published As

Publication number Publication date
CA2500649C (en) 2011-07-12
US7737176B2 (en) 2010-06-15
ATE477232T1 (de) 2010-08-15
FR2845087B1 (fr) 2004-12-24
CY1110814T1 (el) 2015-06-10
KR20050070026A (ko) 2005-07-05
ZA200503416B (en) 2006-12-27
RU2005113717A (ru) 2006-01-20
JP2006501284A (ja) 2006-01-12
MXPA05003388A (es) 2005-06-22
SI1546083T1 (sl) 2010-11-30
ES2350101T3 (es) 2011-01-18
CA2500649A1 (en) 2004-04-15
PT1546083E (pt) 2010-11-17
DE60333765D1 (de) 2010-09-23
WO2004031116A1 (en) 2004-04-15
BR0314826A (pt) 2005-08-02
FR2845087A1 (fr) 2004-04-02
JP4486499B2 (ja) 2010-06-23
CN1688534A (zh) 2005-10-26
AU2003255412A1 (en) 2004-04-23
EP1546083B1 (en) 2010-08-11
US20060052447A1 (en) 2006-03-09
EP1546083A1 (en) 2005-06-29
DK1546083T3 (da) 2010-10-04
AU2003255412B2 (en) 2009-09-10
CN1325462C (zh) 2007-07-11

Similar Documents

Publication Publication Date Title
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
TWI320406B (en) Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
IL193252A0 (en) N-hydroxyacrylamide compounds
MY142029A (en) Phenoxyacetic acid derivatives
CA2534571A1 (en) Substituted isoquinoline derivatives and methods of use
TW200833326A (en) Chemical compounds 572
JO2372B1 (en) Source drugs of 4-phenylpyridine derivatives
MX2008014101A (es) Acidos carboxilicos sustituidos con 4,5-difenil-pirimidinilamino, metodo para su produccion y su uso como medicamentos.
MY138708A (en) Biaryloxymethylarenecarboxylic acids
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
EP2682387A3 (en) C7-fluoro substituted tetracycline compounds
IL193771A (en) Preparations that act as protein inhibitors deliver cholesterol ester
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
MX2008010884A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1.
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
TNSN07435A1 (en) Novel piperidine carboxylic acid amide derivatives
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
MXPA05010020A (es) Derivados de oxamida.
WO2003070728A3 (en) Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
SI1546083T1 (sl) Nove substituirane arilheksadienojske kisline in njihovi estri ki se lahko uporabljajo za zdravljenje in preprečevanje diabetesa dislipidemije in ateroskleroze farmacevtski sestavki ki jih vsebujejo in postopek njihove priprave
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
AU2005238141A8 (en) Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
MXPA04006888A (es) Prucaloprida-n-oxido.
ZA200706705B (en) Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
WO2007110876A3 (en) Novel sulfonanilide derivatives, pharmaceutical compositions comprising the same and process thereof

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)